Second Sight Medical Products Inc., a developer of implantable visual prosthetics to restore some useful vision to blind patients, reported the publication of a positive 3-year FLORA (Functional Low-Vision Observer Rated Assessment) study in the Australian journal Clinical And Experimental Optometry for the Argus II retinal prosthesis system. The FLORA, a multi-part instrument that was developed specifically for use in patients implanted with a retinal prosthesis who suffer from profound loss of vision or blindness, was used to assess the functional visual abilities of 26 blind patients and how they use the Argus II to complete a series of common activities of daily living.